Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 2 (2005), Issue 12 (December)

1. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
   N Engl J Med, 353(22): 2335-41. [Abstract] [Full-text]
2. Electronic surveillance system for monitoring surgical antimicrobial prophylaxis.
   Pediatrics, 116(6): 1317-22. [Abstract] [Full-text]
3. Using a preprinted order sheet to reduce prescription errors in a pediatric emergency department: a randomized, controlled trial.
   Pediatrics, 116(6): 1299-302. [Abstract] [Full-text]
4. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
   Lancet Oncol, 6(12): 945-52. [Abstract] [Full-text]
5. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin.
   Clin Cancer Res, 11(23): 8476-85. [Abstract] [Full-text]
6. Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
   Clin Cancer Res, 11(23): 8413-7. [Abstract] [Full-text]
7. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
   Clin Cancer Res, 11(23): 8403-12. [Abstract] [Full-text]
8. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
   Clin Cancer Res, 11(23): 8398-402. [Abstract] [Full-text]
9. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
   Clin Cancer Res, 11(23): 8258-64. [Abstract] [Full-text]
10. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
    Ophthalmology, 112(12): 2088-94. [Abstract] [Full-text]
11. Time course and morphology of vascular effects associated with photodynamic therapy.
    Ophthalmology, 112(12): 2061-9. [Abstract] [Full-text]
12. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial.
    Lancet, 366(9501): 1935-44. [Abstract] [Full-text]
13. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Ophthalmology, 112(12): 2070-5. [Abstract] [Full-text]
14. Effects of unconditioned and conditioned social defeat on alcohol self-administration and reinstatement of alcohol seeking in rats.
    Psychopharmacology (Berl), 183(3): 341-9. [Abstract] [Full-text]
15. Intense cocaine self-administration after episodic social defeat stress, but not after aggressive behavior: dissociation from corticosterone activation.
    Psychopharmacology (Berl), 183(3): 331-40. [Abstract] [Full-text]
16. Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone.
    Int J Cancer, 118(3): 773-9. [Abstract] [Full-text]
17. Dextran-spermine-based polyplexes--evaluation of transgene expression and of local and systemic toxicity in mice.
    Biomaterials, 27(8): 1636-45. [Abstract] [Full-text]
18. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.
    Biomaterials, 27(8): 1608-16. [Abstract] [Full-text]
19. Galactose-PEG dual conjugation of beta-(1-->3)-D-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake.
    Biomaterials, 27(8): 1626-35. [Abstract] [Full-text]
20. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels.
    Biomaterials, 27(8): 1579-85. [Abstract] [Full-text]
21. Glucose-responsive UV polymerised dextran-concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery.
    Biomaterials, 27(8): 1586-97. [Abstract] [Full-text]
22. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
    Oncology, 69(4): 348-53. [Abstract] [Full-text]
23. A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
    Oncology, 69(4): 333-41. [Abstract] [Full-text]
24. Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.
    Oncology, 69(4): 295-300. [Abstract] [Full-text]
25. Combination chemotherapy in advanced small bowel adenocarcinoma.
    Oncology, 69(4): 290-4. [Abstract] [Full-text]
26. An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.
    Oncology, 69(4): 283-9. [Abstract] [Full-text]
27. Present status and perspectives in the treatment of hormone-refractory prostate cancer.
    Oncology, 69(4): 273-82. [Abstract] [Full-text]
28. Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report.
    Onkologie, 28(12): 653-6. [Abstract] [Full-text]
29. Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study.
    Onkologie, 28(12): 647-50. [Abstract] [Full-text]
30. Prescription pattern of aromatase inhibitors in the adjuvant setting in Germany--final results of a survey among german breast cancer specialists.
    Onkologie, 28(12): 639-44. [Abstract] [Full-text]
31. Relation of time spent in an encounter with the use of antibiotics in pediatric office visits for viral respiratory infections.
    Arch Pediatr Adolesc Med, 159(12): 1145-9. [Abstract] [Full-text]
32. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    J Natl Cancer Inst, 97(23): 1724-33. [Abstract] [Full-text]
33. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
    JAMA, 294(21): 2703-11. [Abstract] [Full-text]
34. Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
    J Clin Microbiol, 43(12): 6183-5. [Abstract] [Full-text]
35. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.
    Proc Natl Acad Sci U S A, 102(49): 17757-62. [Abstract] [Full-text]
36. Finding new tricks for old drugs: an efficient route for public-sector drug discovery.
    Nat Rev Drug Discov, 4(12): 1005-14. [Abstract] [Full-text]
37. Regression of invasive conjunctival squamous carcinoma in an HIV-positive patient on antiretroviral therapy.
    Int J STD AIDS, 16(12): 782-3. [Abstract] [Full-text]
38. Surgical treatment of varicocele by a subinguinal approach combined with antegrade intraoperative sclerotherapy of venous vessels.
    BJU Int, 97(1): 142-5. [Abstract] [Full-text]
39. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    BJU Int, 97(1): 42-7. [Abstract] [Full-text]
40. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
    J Clin Oncol, 23(35): 9001-7. [Abstract] [Full-text]
41. Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
    J Clin Oncol, 23(35): 8992-9000. [Abstract] [Full-text]
42. Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial.
    Cancer Chemother Pharmacol, 57(2): 185-90. [Abstract] [Full-text]
43. Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
    J Clin Oncol, 23(35): 8950-8. [Abstract] [Full-text]
44. Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
    Cancer Chemother Pharmacol, 57(2): 207-12. [Abstract] [Full-text]
45. Toxicity and tissue distribution of magnetic nanoparticles in mice.
    Toxicol Sci, 89(1): 338-47. [Abstract] [Full-text]
46. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial.
    Eur J Vasc Endovasc Surg, 31(1): 93-100. [Abstract] [Full-text]
47. Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.
    Leuk Res, 30(2): 204-10. [Abstract] [Full-text]
48. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.
    Arch Ophthalmol, 123(12): 1644-50. [Abstract] [Full-text]
49. The role of preoperative prophylactic antibiotic administration in periapical endodontic surgery: a randomized, prospective double-blind placebo-controlled study.
    Int Endod J, 38(12): 877-81. [Abstract] [Full-text]
50. Calcium phosphate cements: competitive drug carriers for the musculoskeletal system?
    Biomaterials, 27(10): 2171-7. [Abstract] [Full-text]
51. Highly effective and slow-biodegradable network-type cationic gene delivery polymer: small library-like approach synthesis and characterization.
    Biomaterials, 27(10): 2292-301. [Abstract] [Full-text]
52. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
    Biomaterials, 27(10): 2285-91. [Abstract] [Full-text]
53. Polymeric nanoparticle preparation that eradicates tumors.
    Nano Lett, 5(12): 2552-6. [Abstract] [Full-text]
54. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer.
    Nano Lett, 5(12): 2426-31. [Abstract] [Full-text]
55. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
    Cancer, 104(12): 2862-71. [Abstract] [Full-text]
56. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
    Cancer, 104(12): 2753-8. [Abstract] [Full-text]
57. Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma.
    Cancer, 104(12): 2759-65. [Abstract] [Full-text]
58. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia.
    Cancer, 104(12): 2858-61. [Abstract] [Full-text]
59. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
    Cancer, 104(12): 2766-74. [Abstract] [Full-text]
60. The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
    Cancer, 104(12): 2743-52. [Abstract] [Full-text]
61. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Cancer, 104(12): 2822-9. [Abstract] [Full-text]
62. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
    Cancer, 104(12): 2735-42. [Abstract] [Full-text]
63. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Cancer, 104(12): 2726-34. [Abstract] [Full-text]
64. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
    Cancer, 104(12): 2650-7. [Abstract] [Full-text]
65. Influence of antiinflammatory drugs (methylprednisolone and diclofenac sodium) on experimental pleurodesis induced by silver nitrate or talc.
    Chest, 128(6): 4041-5. [Abstract] [Full-text]
66. A rationale for combination therapy in risk factor management: a mechanistic perspective.
    Am J Med, 118: 54-61. [Abstract] [Full-text]
67. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    J Pediatr, 147(6): 786-90. [Abstract] [Full-text]
68. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia.
    J Pediatr, 147(6): 781-5. [Abstract] [Full-text]
69. Potential medication dosing errors in outpatient pediatrics.
    J Pediatr, 147(6): 761-7. [Abstract] [Full-text]
70. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery.
    Br J Anaesth, 96(1): 21-30. [Abstract] [Full-text]
71. Chemoprevention of colorectal cancer.
    Dis Colon Rectum, 49(1): 113-24; discussion 124-5. [Abstract] [Full-text]
72. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
    Clin Cancer Res, 11(24): 8773-81. [Abstract] [Full-text]
73. Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
    Clin Cancer Res, 11(24): 8728-36. [Abstract] [Full-text]
74. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
    Clin Cancer Res, 11(24): 8715-21. [Abstract] [Full-text]
75. Morphologic alterations associated with mechanical bowel preparation before elective colorectal surgery: a randomized trial.
    Dis Colon Rectum, 49(1): 109-12. [Abstract] [Full-text]
76. Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats.
    Anesth Analg, 102(1): 225-32. [Abstract] [Full-text]
77. An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial.
    Anesth Analg, 102(1): 188-94. [Abstract] [Full-text]
78. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.
    Hypertension, 47(1): 22-8. [Abstract] [Full-text]
79. Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress.
    Blood, 107(1): 241-9. [Abstract] [Full-text]
80. A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 57(3): 309-16. [Abstract] [Full-text]
81. Antithrombotic therapy in atrial fibrillation.
    Clin Geriatr Med, 22(1): 155-66, x. [Abstract] [Full-text]
82. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Clin Geriatr Med, 22(1): 135-54, ix-x. [Abstract] [Full-text]
83. TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.
    Biochem Biophys Res Commun, 340(1): 256-62. [Abstract] [Full-text]
84. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort.
    Int J Cancer, 118(5): 1285-91. [Abstract] [Full-text]
85. Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
    Int J Cancer, 118(5): 1292-301. [Abstract] [Full-text]
86. Drug/device combinations for local drug therapies and infection prophylaxis.
    Biomaterials, 27(11): 2450-67. [Abstract] [Full-text]
87. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds.
    Biomaterials, 27(11): 2468-76. [Abstract] [Full-text]
88. Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia.
    Br J Surg, 93(1): 5-10. [Abstract] [Full-text]
89. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
    N Engl J Med, 353(26): 2758-68. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.